AMAG Pharmaceuticals
AMAG
AMAG was delisted on the 13th of November, 2020.
210 hedge funds and large institutions have $1.78B invested in AMAG Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 95 increasing their positions, 47 reducing their positions, and 47 closing their positions.
102% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 47
9% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 47
1% more funds holding
Funds holding: 208 → 210 (+2)
34% less capital invested
Capital invested by funds: $2.69B → $1.78B (-$904M)
47% less call options, than puts
Call options by funds: $901K | Put options by funds: $1.7M
80% less funds holding in top 10
Funds holding in top 10: 10 → 2 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$73.2M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$65.9M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$65.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.8M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$36.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$42.5M |
| 2 |
TCP
Tourbillon Capital Partners
New York
|
-$31.2M |
| 3 |
Millennium Management
New York
|
-$27.4M |
| 4 |
PC
PointState Capital
New York
|
-$20.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$16.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCS
251
Crosspoint Capital Strategies
Orinda,
California
| – | -$10K | -152 | Closed |
|
252
Walleye Trading
New York
| – | -$7K | -100 | Closed |
|
|
IMS
253
Index Management Solutions
Philadelphia,
Pennsylvania
| – | -$6K | -84 | Closed |
|
|
PIM
254
Parasol Investment Management
Westmont,
Illinois
| – | -$6K | -84 | Closed |
|
255
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$4K | -60 | Closed |
|
|
HMS
256
Hanseatic Management Services
Albuquerque,
New Mexico
| – | -$1K | -15 | Closed |
|
|
NMIS
257
Northwestern Mutual Investment Services
Milwaukee,
Wisconsin
| – | +$497 | +8 | New |
|
AMAG Hedge Fund Activity: Q3 2015 in Review
210 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q3 2015, worth a combined $1.78B — down 34% from $2.69B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new AMAG positions and 47 closed out — a net gain of 4 holders — while 95 added to existing stakes and 47 trimmed.
The largest buyer was Putnam Investments, adding an estimated $73.2M. The largest seller was American Century Companies, cutting an estimated $42.5M.
- 210 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q3 2015, up from 208 in Q2 2015.
- Funds reported $1.78B of AMAG Pharmaceuticals stock for Q3 2015, down 34% quarter-over-quarter.
- 51 funds opened new AMAG Pharmaceuticals positions in Q3 2015 and 47 closed out, a net change of +4 holders.
- The largest AMAG Pharmaceuticals buyer in Q3 2015 was Putnam Investments, an estimated $73.2M added.
- The largest AMAG Pharmaceuticals seller in Q3 2015 was American Century Companies, an estimated $42.5M sold.
Based on aggregated 13F filings for Q3 2015.